Concentrix (NASDAQ:CNXC) Sets New 52-Week Low on Disappointing Earnings

Concentrix Corporation (NASDAQ:CNXC) hit a new 52-week low on Tuesday after the company announced weaker than expected quarterly earnings. The stock traded as low as $24.27 and last traded at $25.4340, with a volume of 2461325 shares. The stock had previously closed at $33.04.

The company reported $2.61 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.64 by ($0.03). Concentrix had a negative net margin of 13.02% and a positive return on equity of 16.91%. The company had revenue of $2.50 billion for the quarter, compared to the consensus estimate of $2.49 billion. During the same period last year, the firm posted $2.79 earnings per share. The company’s revenue for the quarter was up 5.4% compared to the same quarter last year.

Concentrix Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, May 5th. Shareholders of record on Friday, April 24th will be given a $0.36 dividend. This represents a $1.44 dividend on an annualized basis and a dividend yield of 5.4%. The ex-dividend date is Friday, April 24th. Concentrix’s payout ratio is -6.91%.

Trending Headlines about Concentrix

Here are the key news stories impacting Concentrix this week:

• Positive Sentiment: Board declared a quarterly cash dividend of $0.36/share (payable May 5; record April 24), representing a ~5.4% yield — provides near-term income support for shareholders. Concentrix Reports First Quarter 2026 Results
• Positive Sentiment: Company maintained full-year guidance (revenue $10.035–$10.18B; non‑GAAP EPS $11.48–$12.07) and provided Q2 revenue and margin targets — helps limit downside from the print by signaling management confidence in the outlook. Concentrix Reports First Quarter 2026 Results
• Positive Sentiment: Company repurchased ~1M shares in Q1 and has ~$396.6M remaining buyback authorization — supports buy-side demand. Concentrix Reports First Quarter 2026 Results
• Positive Sentiment: Earnings call highlighted strong AI adoption (iX Suite momentum) and growth in banking verticals — strategic growth drivers that investors may view favorably longer-term. Concentrix Corp (CNXC) Q1 2026 Earnings Call Highlights
• Neutral Sentiment: Analyst coverage remains mixed-to-positive (several buy/outperform ratings and price targets well above current levels) — may limit downside but keeps expectations elevated. Concentrix gears up for Q1 print
• Neutral Sentiment: Securitization facility was amended/extended — improves working-capital flexibility but is not a direct earnings driver. Concentrix Expands and Extends Accounts Receivable Securitization Facility
• Negative Sentiment: GAAP results showed a sharp profitability hit: diluted GAAP EPS $0.33 (vs. $1.04 a year ago), net income down ~69%, operating margin compressed — these large earnings and margin declines drove investor concern. Concentrix Reports First Quarter 2026 Results
• Negative Sentiment: Cash flow weakness: operating cash flow was negative and adjusted free cash flow was a use in the quarter — raises short-term liquidity/earnings quality questions. Concentrix Reports First Quarter 2026 Results
• Negative Sentiment: Market reaction: the stock fell sharply on the print (multiple outlets reported sizable intraday drops), reflecting investor disappointment with the earnings/margin/cash-flow metrics despite revenue/guidance stability. Concentrix reports Q1 in line with expectations but stock drops

Analyst Upgrades and Downgrades

A number of analysts have weighed in on the stock. Robert W. Baird set a $52.00 target price on shares of Concentrix in a research report on Wednesday, January 14th. Barrington Research restated an “outperform” rating and issued a $62.00 price target on shares of Concentrix in a research report on Tuesday, March 17th. Wall Street Zen raised shares of Concentrix from a “hold” rating to a “buy” rating in a research note on Saturday, February 14th. Finally, Weiss Ratings cut shares of Concentrix from a “hold (c-)” rating to a “sell (d)” rating in a research report on Thursday, January 29th. Three equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, Concentrix presently has an average rating of “Hold” and a consensus price target of $63.75.

Insiders Place Their Bets

In related news, CEO Christopher A. Caldwell purchased 1,000 shares of the firm’s stock in a transaction that occurred on Thursday, January 29th. The stock was acquired at an average price of $37.07 per share, for a total transaction of $37,070.00. Following the completion of the acquisition, the chief executive officer owned 362,075 shares of the company’s stock, valued at $13,422,120.25. This represents a 0.28% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 0.90% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of the business. Royal Bank of Canada lifted its stake in Concentrix by 9.5% in the first quarter. Royal Bank of Canada now owns 47,501 shares of the company’s stock valued at $2,643,000 after purchasing an additional 4,133 shares during the last quarter. Goldman Sachs Group Inc. increased its position in Concentrix by 75.1% in the first quarter. Goldman Sachs Group Inc. now owns 423,287 shares of the company’s stock worth $23,552,000 after buying an additional 181,546 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its stake in shares of Concentrix by 17.4% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 146,515 shares of the company’s stock valued at $8,152,000 after buying an additional 21,746 shares during the period. Focus Partners Wealth bought a new stake in shares of Concentrix in the first quarter valued at $781,000. Finally, Geneos Wealth Management Inc. lifted its position in shares of Concentrix by 532.7% during the 1st quarter. Geneos Wealth Management Inc. now owns 620 shares of the company’s stock valued at $34,000 after buying an additional 522 shares during the last quarter. Institutional investors own 90.34% of the company’s stock.

Concentrix Price Performance

The company has a current ratio of 1.40, a quick ratio of 1.40 and a debt-to-equity ratio of 1.67. The stock has a market cap of $1.63 billion, a PE ratio of -1.27, a PEG ratio of 0.35 and a beta of 0.50. The business has a 50-day moving average price of $35.34 and a 200 day moving average price of $40.33.

Concentrix Company Profile

Concentrix Inc (NASDAQ: CNXC) is a global business services company specializing in customer engagement solutions and technology‐driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back‐office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.

Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.